Skip to content

Gerontological Telemonitoring of Older Adults Living in Nursing Homes With COVID-19 Disease

Gerontological Telemonitoring of Older Adults Living in Nursing Homes With Symptoms of Confirmed or Probable COVID-19 Disease

Status
Withdrawn
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04337788
Acronym
COVIDeHPAD
Enrollment
0
Registered
2020-04-08
Start date
2020-05-01
Completion date
2020-09-01
Last updated
2026-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronavirus Infection

Keywords

Covid-19, early gerontologic healthcare

Brief summary

Since the last 3 months the world copes with the novel coronavirus disease : Covid-19 emerged in China in the end of 2019. WHO declared the pandemic situation as a Public Health Emergency around the world on January 2020. Firsts studies emphasized on higher risk to older adults to experience serious health consequences : hospitalizations and mortality, due to multimorbidity and multimedication. Nursing home resident are particulary frailer and vulnerable.

Interventions

OTHERtelehealth applications

telehealth applications during 30 days/patient

Sponsors

University Hospital, Limoges
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Prospective cohort study (here and elsewhere)

Eligibility

Sex/Gender
ALL
Age
75 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Nursing home resident with Covid disease RT-PCR or Chest CT or rapid test * Nursing home resident with Covid-19 disease symptoms : * fever * cough * dyspnea * SPO2\<95% in ambient air (or \<91% in COPD patient) * Diarrhea * Fall or balance disorder * Confusion

Exclusion criteria

* Age \< 75 years * Patient in respiratory distress * No consent

Design outcomes

Primary

MeasureTime frame
Impact of Gerontological telemonitoring on healthcare management for older adults living in Nursing Homes with symptoms of confirmed or probable COVID-19 disease (Death within 30 days).day 30

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 10, 2026